CN101068782A - 合成4－(3－磺酰基苯基)－哌啶类的方法 - Google Patents

合成4－(3－磺酰基苯基)－哌啶类的方法 Download PDF

Info

Publication number
CN101068782A
CN101068782A CNA2005800385658A CN200580038565A CN101068782A CN 101068782 A CN101068782 A CN 101068782A CN A2005800385658 A CNA2005800385658 A CN A2005800385658A CN 200580038565 A CN200580038565 A CN 200580038565A CN 101068782 A CN101068782 A CN 101068782A
Authority
CN
China
Prior art keywords
formula
compound
described method
acid
sulfide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2005800385658A
Other languages
English (en)
Chinese (zh)
Inventor
R·德斯蒙德
P·N·迪瓦恩
C·索内松
D·R·高斯尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NSAB Filial af Neurosearch Sweden AB
Original Assignee
A Carlsson Research AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A Carlsson Research AB filed Critical A Carlsson Research AB
Publication of CN101068782A publication Critical patent/CN101068782A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/24—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by sulfur atoms to which a second hetero atom is attached
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CNA2005800385658A 2004-10-13 2005-10-13 合成4－(3－磺酰基苯基)－哌啶类的方法 Pending CN101068782A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61819404P 2004-10-13 2004-10-13
US60/618,194 2004-10-13

Publications (1)

Publication Number Publication Date
CN101068782A true CN101068782A (zh) 2007-11-07

Family

ID=35501100

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2005800385658A Pending CN101068782A (zh) 2004-10-13 2005-10-13 合成4－(3－磺酰基苯基)－哌啶类的方法

Country Status (10)

Country Link
US (1) US20070238878A1 (ja)
EP (1) EP1807394A1 (ja)
JP (1) JP2008515952A (ja)
KR (1) KR20070064370A (ja)
CN (1) CN101068782A (ja)
AU (1) AU2005293755A1 (ja)
CA (1) CA2584833A1 (ja)
MX (1) MX2007004216A (ja)
NZ (1) NZ555095A (ja)
WO (1) WO2006040156A1 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109369609A (zh) * 2018-11-02 2019-02-22 珠海市赛纬电子材料股份有限公司 一种硫酸乙烯酯的制备方法

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE46117E1 (en) 1999-12-22 2016-08-23 Teva Pharmaceuticals International Gmbh Modulators of dopamine neurotransmission
DE602005017784D1 (de) 2004-06-08 2009-12-31 Nsab, Filial Af Neurosearch Sweden Ab Neue disubstituierte phenylpiperidine als modulatoren der dopamin- und serotoninneurotransmission
SE0401465D0 (sv) 2004-06-08 2004-06-08 Carlsson A Research Ab New substituted piperdines as modulators of dopamine neurotransmission
US7851629B2 (en) 2004-06-08 2010-12-14 Nsab, Filial Af Neurosearch Sweden Ab, Sverige Disubstituted phenylpiperidines as modulators of dopamine and serotonin neurotransmission
HUE029790T2 (hu) 2004-10-13 2017-04-28 Teva Pharmaceuticals Int Gmbh Eljárás 4-(3-metánszulfonil-fenil)-l-N-propil-piperidin elõállítására
SE529246C2 (sv) * 2005-10-13 2007-06-12 Neurosearch Sweden Ab Nya disubstituerade fenyl-piperidiner som modulatorer för dopaminneurotransmission
WO2011107583A1 (en) 2010-03-04 2011-09-09 Nsab, Filial Af Neurosearch Sweden Ab, Sverige Substituted 4-phenyl-n-alkyl-piperidines for preventing onset or slowing progression of neurodegenerative disorders
UY34503A (es) 2011-12-08 2013-07-31 Ivax Int Gmbh ?sal de bromhidrato de pridopidina?
AU2013243461A1 (en) 2012-04-04 2014-11-06 Teva Pharmaceuticals International Gmbh Pharmaceutical compositions for combination therapy
TW201613859A (en) 2014-06-30 2016-04-16 Teva Pharma Analogs of PRIDOPIDINE, their preparation and use
AR105434A1 (es) 2015-07-22 2017-10-04 Teva Pharmaceuticals Int Gmbh Proceso para preparar pridopidina

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE662455A (ja) * 1964-04-14
GB1060160A (en) * 1964-08-05 1967-03-01 Allen & Hanburys Ltd 4-phenylpiperidine derivatives
US3539573A (en) * 1967-03-22 1970-11-10 Jean Schmutz 11-basic substituted dibenzodiazepines and dibenzothiazepines
US3536916A (en) * 1968-04-02 1970-10-27 Radiation Processing Inc Radiation measuring device and technique
US4048314A (en) * 1974-12-17 1977-09-13 Delmar Chemicals Limited Morpholino containing 4-arylpiperidine derivatives
US4202898A (en) * 1978-06-05 1980-05-13 Synthelabo Method of treating anxiety and depression
US4333942A (en) * 1979-08-03 1982-06-08 Byk Gulden Lomberg Chemische Fabrik Gmbh Anti-depressant and analgesic 4-phenoxypiperidines
US4415736A (en) * 1981-12-28 1983-11-15 E. I. Du Pont De Nemours & Co. Certain tetrahydropyridine intermediates
US4485109A (en) * 1982-05-07 1984-11-27 E. I. Du Pont De Nemours And Company 4-Aryl-4-piperidinecarbinols
US4504660A (en) * 1982-07-06 1985-03-12 American Home Products Corporation Process for the production of 2,6-diaminobenzonitrile derivatives
US4501660A (en) * 1983-02-25 1985-02-26 Alfred Hebert Oil filter
CA2105666C (en) * 1991-04-17 2006-02-14 Kjell Anders Ivan Svensson New centrally acting substituted phenylazacycloalkanes
US5502050A (en) * 1993-11-29 1996-03-26 Cornell Research Foundation, Inc. Blocking utilization of tetrahydrobiopterin to block induction of nitric oxide synthesis
HUP9904335A3 (en) * 1996-07-22 2001-07-30 Daiichi Asubio Pharma Co Ltd Arylpiperidinol and arylpiperidine derivatives and drugs containing the same
US5892041A (en) * 1996-08-12 1999-04-06 Neurogen Corporation Fused indolecarboxamides: dopamine receptor subtype specific ligands
SE9904724D0 (sv) * 1999-12-22 1999-12-22 Carlsson A Research Ab New modulators of dopamine neurotransmission I
SE9904723D0 (sv) * 1999-12-22 1999-12-22 Carlsson A Research Ab New modulators of dopamine neurotransmission II
HUE029790T2 (hu) * 2004-10-13 2017-04-28 Teva Pharmaceuticals Int Gmbh Eljárás 4-(3-metánszulfonil-fenil)-l-N-propil-piperidin elõállítására

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109369609A (zh) * 2018-11-02 2019-02-22 珠海市赛纬电子材料股份有限公司 一种硫酸乙烯酯的制备方法

Also Published As

Publication number Publication date
EP1807394A1 (en) 2007-07-18
MX2007004216A (es) 2007-10-10
AU2005293755A1 (en) 2006-04-20
NZ555095A (en) 2010-07-30
WO2006040156A1 (en) 2006-04-20
US20070238878A1 (en) 2007-10-11
KR20070064370A (ko) 2007-06-20
JP2008515952A (ja) 2008-05-15
CA2584833A1 (en) 2006-04-20

Similar Documents

Publication Publication Date Title
CN101068782A (zh) 合成4－(3－磺酰基苯基)－哌啶类的方法
CN1914202A (zh) 1－(2s,3s)－2－二苯甲基－n－(5－叔丁基－2－甲氧基苄基)奎宁环－3－胺的制备方法
CN1756734A (zh) 谷氨酸衍生物和焦谷氨酸衍生物的制造方法和新型的制造用中间体
CN1198805C (zh) 制备光学活性的半酯的方法
CN1286820C (zh) 4－烷氧基－环己烷－1－氨基－羧酸酯及其生产方法
CN1927830A (zh) 光学纯亚磺酰胺化合物及其应用
CN1064964C (zh) 新型苯并二噁烷,它们的制备方法以及含这些化合物的药物组合物
CN1771248A (zh) 制备 1 － n －苯基 － 2 － n －苯基吡咯烷 － 1 , 2 －二甲酰胺衍生物以及作为中间体的 1 －苯基氨基甲酰基吡咯烷－ 2 －羧酸衍生物的方法
CN1878763A (zh) 抑制素制备方法
CN1235967A (zh) 咔唑酮衍生物
CN1852885A (zh) 腈化合物、羧酸化合物或羧酸酯化合物的制备方法
CN1377337A (zh) 苯乙酸衍生物的制备方法
CN1370151A (zh) 2－氨基－4－(4－氟苯基)－6－烷基嘧啶－5－羧酸酯的制备方法
CN1968941A (zh) 3－氨基甲基四氢呋喃衍生物的制备方法
CN1138850A (zh) 制备对映体纯环戊烷-和环戊烯-β-氨基酸的新型高对映体选择性方法
CN101054355A (zh) 光学纯双亚磺酰胺化合物及其应用
CN1178934C (zh) 苯并呋喃衍生物
CN1486316A (zh) 卡巴培南类抗菌剂的制造方法
CN1875018A (zh) 制备噻唑烷二酮的方法
CN1315319A (zh) 乙磺酰哌啶衍生物的制备方法
CN1759100A (zh) 一种制备4－氨甲基－3－烷氧基亚氨基吡咯烷甲磺酸的新方法
CN1874974A (zh) 通过使用改进在包括环境温度的所有温度下的非对映选择性的特定膦酸酯的 H o r n e r － W a d s wo r t h －E m m o n s反应来制备烯烃的非对映选择方法
CN1784378A (zh) 4－羟基异亮氨酸及其衍生物的合成方法
CN1286832C (zh) 吲哚化合物的制备方法
CN1160350C (zh) 制备手性内酯的方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20090206

Address after: Denmark and Rupp

Applicant after: Nsab Af Neurosearch Sweden AB

Address before: Gothenburg

Applicant before: Carlsson Res AB A.

ASS Succession or assignment of patent right

Owner name: NSAB SWEDEN S NERVE RESEARCH BRANCH CORPORATION

Free format text: FORMER OWNER: SWEDEN S NERVE RESEARCH

Effective date: 20090206

AD01 Patent right deemed abandoned

Effective date of abandoning: 20071107

C20 Patent right or utility model deemed to be abandoned or is abandoned